180 related articles for article (PubMed ID: 26606748)
1. Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
Gozzard P; Chapman C; Vincent A; Lang B; Maddison P
PLoS One; 2015; 10(11):e0143558. PubMed ID: 26606748
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
Maddison P; Lang B
J Neuroimmunol; 2008 Sep; 201-202():159-62. PubMed ID: 18667241
[TBL] [Abstract][Full Text] [Related]
3. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
5. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.
Gozzard P; Woodhall M; Chapman C; Nibber A; Waters P; Vincent A; Lang B; Maddison P
Neurology; 2015 Jul; 85(3):235-9. PubMed ID: 26109714
[TBL] [Abstract][Full Text] [Related]
7. Impact of PET staging in limited-stage small-cell lung cancer.
Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
Vernino S; Tuite P; Adler CH; Meschia JF; Boeve BF; Boasberg P; Parisi JE; Lennon VA
Ann Neurol; 2002 May; 51(5):625-30. PubMed ID: 12112110
[TBL] [Abstract][Full Text] [Related]
10. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
11. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
Cho O; Oh YT; Chun M; Noh OK; Lee HW
Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
14. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
Shojaee S; Singh I; Solsky I; Nana-Sinkam P
Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
[TBL] [Abstract][Full Text] [Related]
15. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
[TBL] [Abstract][Full Text] [Related]
17. Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma.
Fan S; Guan Y; Zhao G; An G
Thorac Cancer; 2018 Jan; 9(1):146-151. PubMed ID: 29131503
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer.
Dericioglu N; Gocmen R; Tan E
Clin Neurol Neurosurg; 2018 Jul; 170():117-119. PubMed ID: 29777943
[No Abstract] [Full Text] [Related]
19. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
20. CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.
Yang X; Wang D; Yang Z; Qing Y; Zhang Z; Wang G; Yang Z; Wang Z
Cell Biochem Biophys; 2011 Mar; 59(2):113-9. PubMed ID: 20945115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
